Biophotonics Global Market Outlook to 2026-By Technology, Technology, Application and Region

2021-11-16 19:28:33 By : Ms. candy zhu

Call 888-776-0942 from 8 a.m. to 10 p.m. Eastern Time

Dublin, October 22, 2021/PRNewswire/-ResearchAndMarkets.com has added the "Biophotonics Market: Global Industry Trends, Share, Scale, Growth, Opportunities and Forecasts 2021-2026" report to the products.

In 2020, the global biophotonics market will be worth 56.5 billion U.S. dollars. Looking ahead, the market is expected to grow at a compound annual growth rate of 10.3% during the period 2021-2026. Keeping in mind the uncertainty of COVID-19, analysts are constantly tracking and evaluating the direct and indirect impact of the pandemic on different end-use sectors. These insights are included in the report as major market contributors. Biophotonics refers to the multidisciplinary research field that uses light-based technology to study life sciences and medicine. It involves the production and use of light sources to detect and manipulate biological materials. Technologies based on fluoroscopy imaging, internal imaging, molecular spectroscopy, microscopy, analytical sensing and biosensing solutions such as spectroscopy, photodynamics, and fiber optic sensors are used to study biological tissues, cells, and molecules. These technologies facilitate the emission, detection, absorption, reflection, and modification of radiation from biomolecules and biomaterials. Therefore, biophotonics is widely used in the fields of life sciences, agriculture, environmental sciences, dentistry and medicine. The increasing prevalence of chronic diseases and the widespread adoption of biophotonics in disease diagnosis are one of the key factors driving market growth. The increase in the elderly population makes it more likely to suffer from this disease, which also promotes the growth of the market. In addition, the widespread adoption of biophotonics in non-medical fields is creating positive prospects for the market. It is used to test chemicals, toxins and microbial materials for environmental monitoring and defense applications. In addition, various technological advancements, such as nanotechnology and the emergence of new photoacoustic tomography (PAT) systems, are acting as other growth-inducing factors. These systems use gold and silica nanoparticles for biomedical imaging and accurate detection of cancer cells in patients. Other factors, including increased investment in the development of protein, nucleic acid, and virus diagnostic and testing facilities, as well as extensive research and development (R&D) activities, are expected to further drive the market.

The report also analyzes the competitive landscape of the market. Some of the main players are Andor Technology Ltd. (Oxford Instruments Plc), BD (Becton, Dickinson and Company), Carl Zeiss AG (Carl-Zeiss-Stiftung), Glenbrook Technologies Inc. , Hamamatsu Photonics KK, Lumenis Ltd., Olympus Corporation, Perkinelmer Inc., Thermo Fisher Scientific Inc. and Zecotek Photonics Inc. Key questions answered in this report

Key topics covered: 1 Foreword 2 Scope and methodology 3 Executive summary 4 Introduction 4.1 Overview 4.2 Key industry trends 5 Global biophotonics market 5.1 Market overview 5.2 Market performance 5.3 Impact of COVID-19 5.4 Market forecast 6 Market segmentation 6.1 Surface imaging 6.1.1 Market Trend 6.1.2 Market Forecast 6.2 Molecular Spectroscopy 6.2.1 Market Trend 6.2.2 Market Forecast 6.3 Microscope 6.3.1 Market Trend 6.3.2 Market Forecast 6.4 Light Therapy 6.4.1 Market Trend 6.4.6.5 Biosensor Market Forecast 1 Market Trend 6.5.2 Market Forecast 6.6 Internal Imaging 6.6.1 Market Trend 6.6.2 Market Forecast 6.7 Perspective Imaging 6.7.1 Market Trend 6.7.2 Market Forecast 6.8 Other 6.8.1 Market Trend 6.8.2 Market Forecast 7 Market by Technology Segmentation 7.1 In vitro 7.1.1 Market Trends 7.1.2 Market Forecasts 7.2 In vivo 7.2.1 Market Trends 7.2.2 Market Forecasts 8 Market Segmentation by Application 8.1 Medical Diagnostics 8.1.1 Market Trends 8.1.2 Market Forecasts 8.2 Idical Therapeutics 8.2 .1 Market trends 8.2.2 Market forecasts 8.3 Material testing 8.3.1 Market trends 8.3.2 Market forecasts 8.4 Other 8.4.1 Market trends 8.4.2 Market forecasts 9 Market segmentation by region

10 SWOT Analysis 11 Value Chain Analysis 12 Porter's Five Forces Analysis 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Main Participants 14.3 Main Participants Profile 14.3.1 Andor Technology Ltd (Oxford Instruments PLC) 14.3.1.1 Company Overview 14.3.1 Product portfolio 14.3.1.3 Finance 14.3.2 BD (Becton, Dickinson and Company) 14.3.2.1 Company overview 14.3.2.2 Product portfolio 14.3.2.3 Finance 14.3.2.4 SWOT analysis 14.3.3 Carl Zeiss AG (Carl-14ft3) Company overview 14.3 .3.2 Product portfolio 14.3.3.3 Financial 14.3.3.4 SWOT analysis 14.3.4 Glenbrook Technologies Inc. 14.3.4.1 Company overview 14.3.4.2 Product portfolio 14.3.5 Hamamatsu Photonics KK.14.3.3 Overview 14.3.5.2.5 Product portfolio 14.3. 5.2.5.3 Finance 14.3.6 Lumenis Ltd. 14.3.6.1 Company overview 14.3.6.2 Product portfolio 14.3.6.3 SWOT analysis 14.3.7 Olympus Corporation 14.3.7.1 Company overview 14.3.7.2 Product portfolio 14.3.3.4.4 SWOT analysis 14.3.4.4 SWOT analysis 3.8 Perkinelmer Inc. 14.3.8.1 Company overview 14.3.8.2 Product portfolio 14.3.8.3 Finance 14.3.8.4 SWOT analysis 14.3.9 Thermo Fisher Scientific Inc. 14.3.9.1 Company overview 14.3.9.2 Product portfolio. 91.134. Financial analysis 3. SWOT9 14.3.10 Zecotek Photonics Inc. 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Finance 14.3.10.4 SWOT Analysis For more information on this report, please visit https://www.researchandmarkets.com/r/7as5af

Media Contact: Laura Wood, Senior Manager, Research and Marketing Department [email protection]       

Call 1-917-300-0470 during EST office hours toll-free number 1-800-526-8630 GMT during office hours in the United States/Canada, dial 353-1-416-8900 during office hours

US Fax: 646-607-1904 Fax (Outside the US): 353-1-481-1716

More news releases on similar topics

Cision Distribution 888-776-0942 8 a.m. to 9 p.m. Eastern Time